Changes to the Code
S. 3267 · Alzheimer's Screening and Prevention Act · Introduced The text as a member of Congress first filed it. Most bills never get further than this.
A bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of blood-based dementia screening tests.
In committee · step 2 of 5
42 U.S.C. § 1395l Payment of benefits
1 change the bill asks for here, 1 carried out
- Carried out:
Section 1833(h)(1)(A) of the Social Security Act (42 U.S.C. 1395l(h)(1)(A)) is amended by inserting
Alzheimer’s disease and related dementias early detection screening tests under section 1861(nnn) and
afterincluding
.
§ 1395l(h)Fee schedules for clinical diagnostic laboratory tests; percentage of prevailing charge level; nominal fee for samples; adjustments; recipients of payments; negotiated payment rate(1)
Start of § 1395l to (g)(8) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (h) | (h) Fee schedules for clinical diagnostic laboratory tests; percentage of prevailing charge level; nominal fee for samples; adjustments; recipients of payments; negotiated payment rate | (h) Fee schedules for clinical diagnostic laboratory tests; percentage of prevailing charge level; nominal fee for samples; adjustments; recipients of payments; negotiated payment rate | ||
| (1) | (1) | (1) | ||
| (1)(A) | (A) | (A) | ||
| Subject to subsections (d)(1) and (aa) of section 1395m of this title, the Secretary shall establish fee schedules for clinical diagnostic laboratory tests (including prostate cancer screening tests under section 1395x(oo) of this title consisting of prostate-specific antigen blood tests) for which payment is made under this part, other than such tests performed by a provider of services for an inpatient of such provider. | Subject to subsections (d)(1) and (aa) of section 1395m of this title, the Secretary shall establish fee schedules for clinical diagnostic laboratory tests (including [inserted: Alzheimer’s disease and related dementias early detection screening tests under section 1861(nnn) and ]prostate cancer screening tests under section 1395x(oo) of this title consisting of prostate-specific antigen blood tests) for which payment is made under this part, other than such tests performed by a provider of services for an inpatient of such provider. | |||
| (1)(B) | (B) | (B) | ||
| In the case of clinical diagnostic laboratory tests performed by a physician or by a laboratory (other than tests performed by a qualified hospital laboratory (as defined in subparagraph (D)) for outpatients of such hospital), the fee schedules established under subparagraph (A) shall be established on a regional, statewide, or carrier service area basis (as the Secretary may determine to be appropriate) for tests furnished on or after July 1, 1984. | In the case of clinical diagnostic laboratory tests performed by a physician or by a laboratory (other than tests performed by a qualified hospital laboratory (as defined in subparagraph (D)) for outpatients of such hospital), the fee schedules established under subparagraph (A) shall be established on a regional, statewide, or carrier service area basis (as the Secretary may determine to be appropriate) for tests furnished on or after July 1, 1984. | |||
| (1)(C) | (C) | (C) | ||
| In the case of clinical diagnostic laboratory tests performed by a qualified hospital laboratory (as defined in subparagraph (D)) for outpatients of such hospital, the fee schedules established under subparagraph (A) shall be established on a regional, statewide, or carrier service area basis (as the Secretary may determine to be appropriate) for tests furnished on or after July 1, 1984. | In the case of clinical diagnostic laboratory tests performed by a qualified hospital laboratory (as defined in subparagraph (D)) for outpatients of such hospital, the fee schedules established under subparagraph (A) shall be established on a regional, statewide, or carrier service area basis (as the Secretary may determine to be appropriate) for tests furnished on or after July 1, 1984. |
Rest of § 1395l unchanged
42 U.S.C. § 1395x Definitions
3 changes the bill asks for here, 2 carried out
- Not carried out:
in subparagraph (JJ), by striking the semicolon at the end and inserting
;
and; and
The bill strikes “;” at the end of § 1395x(s)(2)(JJ), but the text there doesn't end with it. The law may have changed since the bill was drafted.
Technical detail
“;” is not at the end of /us/usc/t42/s1395x/s/2/JJ - Carried out:
by adding at the end the following new subparagraph:
(KK) Alzheimer’s disease and related dementias early detection screening tests (as defined in subsection (nnn)); and
The section already has a provision under this letter or number, so it would have two.
- Carried out:
by adding at the end the following new subsection:
(nnn) Alzheimer’s disease and related dementias early detection screening tests.— The term “Alzheimer’s disease and related dementias early detection screening test” means a test furnished to an individual for the detection of the pre-symptomatic and early stage of Alzheimer’s …
The section already has a provision under this letter or number, so it would have two.
This bill puts a provision under a letter or number this section already uses, so the section would have two. The law has probably changed since the bill was written.
§ 1395x(s)Medical and other health services(2)–(4)
Start of § 1395x to (s)(2)(II) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (2)(JJ) | (JJ) | (JJ) | ||
| lymphedema compression treatment items (as defined in subsection (mmm)); and | lymphedema compression treatment items (as defined in subsection (mmm)); and | |||
| (2)(KK) | (KK) | (KK) | ||
| multi-cancer early detection screening tests (as defined in subsection (nnn)); | multi-cancer early detection screening tests (as defined in subsection (nnn)); | |||
| (2)(KK) | (KK) [inserted: ] | |||
| [inserted: Alzheimer’s disease and related dementias early detection screening tests (as defined in subsection (nnn));] | ||||
| (3) | (3) | (3) | ||
| diagnostic X-ray tests (including tests under the supervision of a physician, furnished in a place of residence used as the patient’s home, if the performance of such tests meets such conditions relating to health and safety as the Secretary may find necessary and including diagnostic mammography if conducted by a facility that has a certificate (or provisional certificate) issued under section 354 of the Public Health Service Act [42 U.S.C. 263b]), diagnostic laboratory tests, and other diagnostic tests; | diagnostic X-ray tests (including tests under the supervision of a physician, furnished in a place of residence used as the patient’s home, if the performance of such tests meets such conditions relating to health and safety as the Secretary may find necessary and including diagnostic mammography if conducted by a facility that has a certificate (or provisional certificate) issued under section 354 of the Public Health Service Act [42 U.S.C. 263b]), diagnostic laboratory tests, and other diagnostic tests; | |||
| (4) | (4) | (4) | ||
| X-ray, radium, and radioactive isotope therapy, including materials and services of technicians; | X-ray, radium, and radioactive isotope therapy, including materials and services of technicians; | |||
§ 1395x(nnn)–(nnn)
(s)(5)–(nnn)(1) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (nnn)(1)(C)(ii) | (ii) | (ii) | ||
| appropriate for individuals entitled to benefits under part A or enrolled under part B. | appropriate for individuals entitled to benefits under part A or enrolled under part B. | |||
| (nnn)(2) | (2) NCD process | (2) NCD process | ||
| In making determinations under paragraph (1)(C) regarding the coverage of a new test, the Secretary shall use the process for making national coverage determinations (as defined in section 1395ff(f)(1)(B) of this title) under this subchapter. | In making determinations under paragraph (1)(C) regarding the coverage of a new test, the Secretary shall use the process for making national coverage determinations (as defined in section 1395ff(f)(1)(B) of this title) under this subchapter. | |||
| (nnn) | (nnn) [inserted: Alzheimer’s disease and related dementias early detection screening tests.—] | |||
| [inserted: The term “Alzheimer’s disease and related dementias early detection screening test” means a test furnished to an individual for the detection of the pre-symptomatic and early stage of Alzheimer’s disease or related dementias on or after January 1, 2028, that—] | ||||
| (nnn)(1) | (1) [inserted: ] | |||
| [inserted: is cleared under section 510(k), classified under section 513(f)(2), or approved under section 515 of the Federal Food, Drug, and Cosmetic Act; and] | ||||
| (nnn)(2) | (2) [inserted: ] | |||
| [inserted: is—] | ||||
| (nnn)(2)(A) | (A) [inserted: ] | |||
| [inserted: a genomic sequencing blood or blood product test; or] | ||||
| (nnn)(2)(B) | (B) [inserted: ] | |||
| [inserted: such other equivalent test, including a single-analyte test, blood test analysis of cell-free nucleic acids, multiplex panel test, whole genome sequencing, protein expression, whole exome, whole transcriptome, and medical imaging (which are based on blood, blood products, tissue, urine or other biospecimen), as the Secretary determines appropriate in providing results comparable to those obtained with a test described in subparagraph (A).] | ||||